Age 30–49 | Age 50–59 | Age 60–69 | Age 70–79 | Age 80 - | Total | |
---|---|---|---|---|---|---|
LDL-C TARGET REACHED | ||||||
Women without LLM | ||||||
Yes, n (%) | 119 (50.4) | 132 (37.5) | 250 (41.5) | 235 (47.2) | 192 (55.7) | 928 (45.6) |
Women with LLM | ||||||
Yes, n (%) | 15 (55.6) | 75 (48.1) | 436 (62.1) | 595 (70.0) | 383 (66.6) | 1504 (65.1) |
Men without LLM | ||||||
Yes, n (%) | 80 (41.2) | 100 (36.8) | 207 (46.1) | 175 (54.4) | 90 (66.2) | 652 (47.5) |
Men with LLM | ||||||
Yes, n (%) | 27 (42.9) | 90 (54.9) | 362 (68.2) | 337 (71.6) | 121 (70.8) | 937 (66.9) |
LIPID-LOWERING MEDICATION | ||||||
Women | ||||||
Yes, n (%) | 27 (10.3) | 156 (30.7) | 702 (53.8) | 850 (63.0) | 575 (62.5) | 2310 (53.2) |
Men | ||||||
Yes, n (%) | 63 (24.5) | 164 (37.6) | 531 (54.2) | 471 (59.4) | 171 (55.7) | 1400 (50.5) |